Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$9.87 - $11.8 $4.16 Million - $4.97 Million
421,362 Added 52.11%
1,230,000 $13 Million
Q4 2023

Feb 14, 2024

BUY
$8.38 - $11.58 $6.78 Million - $9.36 Million
808,638 New
808,638 $9.08 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.95B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Philosophy Capital Management LLC Portfolio

Follow Philosophy Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Philosophy Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Philosophy Capital Management LLC with notifications on news.